Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

ReGenTree begins ARISE-3 trial of RGN-259 for dry eye

RGN-259 is a sterile, preservative-free eye drop formulation being developed for dry eye syndrome and neurotrophic keratitis. Credit: LaitrKeiows.



  • ReGenTree begins ARISE-3 trial of RGN-259 for dry eye
Close
Close
Close

Go Top